PerkinElmer acquires Chinese diagnostics firm

By Mass High Tech staff

Video Gallery

MHT's Julie Donnelly: Life science startups finding investments

MHT's Marc Songini: Technology to keep seniors healthy

MHT's Marc Songini: RI plans launch of cord blood center

OncoPep licenses cancer vaccine, moves to add $500K to Series A [February 13, 2012]

Spin Transfer whips up $36M in first round [February 13, 2012]

Oxford Immunotec taps Altieri as CFO [February 13, 2012]

SeraCare selling to Linden for $82M [February 13, 2012]

Waltham-based lab and research gear provider PerkinElmer Inc. has expanded its prenatal and neonatal diagnostic offerings globally by acquiring Shanghai-based diagnostics supplier SYM-BIO Lifescience for about $63.7 million.

The newly acquired company focuses its diagnostics business on infectious diseases and opens PerkinElmer’s customer base to hospitals in China. The transaction also grants PerkinElmer access to a manufacturing facility in the Shanghai region.

SYM-BIO Lifescience develops time-resolved fluorometry (TRF) instruments for scientific research, according to the company’s website.

PerkinElmer (NYSE: PKI) reported revenue of approximately $2 billion in 2008. It has some 8,500 employees with customers in over 150 countries. In April, PerkinElmer announced the appointment of new CFO Frank Wilson, who also serves as the company’s senior vice president and chief accounting officer. The position, company officials said, would give Wilson overall leadership responsibility for the strategy and operations of PerkinElmer’s finance and control operations.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.